4161 - 4170 of 6255 Results
Title
Year
-
OPENTitle: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in miceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-24567-xBest OA location URL: https://escholarship.org/uc/item/35j6s17tCitation Count: 9
- Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-Branch2020OPENTitle: Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-BranchJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 6Start Page: 1442End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9061442Best OA location URL: https://www.mdpi.com/2073-4409/9/6/1442/pdf?version=1592474637Citation Count: 20
-
OPENTitle: Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson’s Disease and parkinsonismJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03506-xBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03506-xCitation Count: 1
-
OPENTitle: NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian EfficacyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.30175Best OA location URL: https://doi.org/10.1002/mds.30175Citation Count: 1
- Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET2018OPENTitle: Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PETJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 652End Page: 660Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.022Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.022Citation Count: 27
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 1End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/10543406.2023.2170400Citation Count: 7
-
OPENTitle: CSF alpha‐synuclein aggregates by seed amplification and clinical presentation of ADJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 8Start Page: 3754End Page: 3759Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13109Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13109Citation Count: 31
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X251356503Citation Count: 0
-
OPENTitle: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled ImagesJournal Name: CellPublisher: Elsevier BVVol: 173Issue #: 3Start Page: 792End Page: 803.e19Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040Best OA location URL: http://www.cell.com/article/S0092867418303647/pdfCitation Count: 609
- Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness2017OPENTitle: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepinessJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 43Issue #:Start Page: 25End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2017.11.1137Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/83291977/Increased_dopaminergic_function_in_YOUSAF_Firstonline12December2017_GREEN_AAM_CC_BY_NC_ND_.pdfCitation Count: 13